Results 201 to 210 of about 5,691,277 (301)

Identification and quantification of Δ‐9‐tetrahydrocannabinol and the synthetic cannabinoid MDMB‐4en‐PINACA in edible products seized by United Kingdom police in 2024

Addiction, EarlyView.
Abstract Background and aims Cannabis edible products are increasingly being sold on the illicit market around the world. Use of these products, typically labelled as containing Δ‐9‐tetrahydrocannabinol (THC), has been linked to adverse health effects, particularly amongst adolescents.
Matthew Gardner, Kathryn Proctor, Martha Old, Gyles Cozier, Oliver Sutcliffe, Jennifer Scott, Stephen M. Husbands, Tom P. Freeman, Peter Sunderland, Christopher R. Pudney   +9 more
wiley   +1 more source

Drug use disorders among people convicted of large‐, moderate‐ and small‐scale drug supply crimes: A register‐based retrospective comparative study

Addiction, EarlyView.
Abstract Background and aims Heavy drug use has been associated with small‐scale drug crime, but the substance use histories of individuals involved in the manufacturing, smuggling and wholesaling of larger quantities of drugs [here referred to as serious drug crimes (SDC)] have been largely unexamined.
Julie Elizabeth Brummer, Freja Ilsing Magnussen, Morten Hesse, Thomas Friis Søgaard   +3 more
wiley   +1 more source

Clinical Experience and Student Support for Medical Cannabis Use: A Secondary Analysis. [PDF]

Cannabis
Tong AW, DuBoux CJ, Seuferer RH, Clobes TA, Siu FW, Magana B, Gold JM, Bensing-Ruiz J.   +7 more
europepmc   +1 more source

Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology

Addiction, EarlyView.
Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke, Johan Duflou, Agata Chrzanowska, Michael Farrell, Julia Lappin, Amy Peacock   +5 more
wiley   +1 more source

Medical cannabis utilization in children - a study based on a nationwide cohort. [PDF]

Front Pharmacol
Treves N, Yakirevich-Amir N, Allegaert K, van den Anker JN, Kohn E, Berlin M, Hazan A, Davidson E, Berkovitch M, Bonne O, Stolar OE, Matok I.   +11 more
europepmc   +1 more source

When psychedelic discourse meets local narrative: Selective uptake of psychedelic meanings surrounding mad honey in Nepal

Addiction, EarlyView.
Abstract Aims ‘Mad honey’ is produced when bees collect nectar from Rhododendron species containing grayanotoxins, naturally occurring diterpenoid toxins that can produce dose‐dependent intoxication. It has long been embedded in Nepalese medicinal and ritual practices but has recently become part of global psychedelic discourse. This study examined how
Sharon R. Sznitman, Surendra Tiwari
wiley   +1 more source

Investigating medical cannabis for adolescents with Tourette syndrome: tread carefully. [PDF]

BJPsych Open
Abi-Jaoude E.
europepmc   +1 more source

Polygenic prediction of cannabis‐related outcomes: Evidence from the Avon Longitudinal Study of Parents and Children longitudinal cohort and the European gene–environment interaction case–control study

Addiction, EarlyView.
Abstract Background and aims Polygenic risk scores (PRSs) for cannabis use disorder (CUD), major depressive disorder (MDD), insomnia and chronic pain, and early age at cannabis initiation might be linked to problematic cannabis use. We tested whether: (1) higher PRS for CUD, MDD, insomnia and chronic pain are associated with earlier initiation and ...
Edoardo Spinazzola, Isabelle Austin‐Zimmerman, Giulia Trotta, Zhikun Li, Perry B. M. Leung, Edward Chesney, Qiang Li, Luis Alameda, Celso Arango, Michael O'Donovan, Jim van Os, Pak C. Sham, Craig Morgan, Evangelos Vassos, Diego Quattrone, Tom Freeman, Marta Di Forti, Robin M. Murray   +17 more
wiley   +1 more source

Unmet Healthcare Needs as a Mechanism of Rural-Urban Medical Cannabis Use Disparities Among Sexual Minority Young Adults. [PDF]

J Rural Health
Anderson CB, Romm KF, Vogel EA.
europepmc   +1 more source

Chronic pain treatment experiences and barriers among opioid agonist treatment participants who inject drugs: A qualitative study

Addiction, EarlyView.
Abstract Background and aim Co‐occurring chronic pain affects nearly half of people receiving opioid use disorder (OUD) treatment. Although this pain is often severe, it is usually inadequately managed. Stigma and clinical complexity associated with OUD are thought to further restrict access to pain care.
Jie Yang, Shelley Walker, Amy G. McNeilage, Peter Higgs, Louisa Picco, Paul Dietze, Suzanne Nielsen   +6 more
wiley   +1 more source